News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Aphios Awarded Phase I of Fast Track SBIR Grant from SBIR for Novel Alzheimer's Disease Nanodrug


11/30/2010 9:13:51 AM

WOBURN, Mass.--(BUSINESS WIRE)--Aphios® Corporation today announced that it was awarded Phase I of a Fast Track SBIR grant from the National Institute of Aging (NIA), National Institutes of Health (NIH) for Developing a Novel Alzheimer’s Disease Nanodrug.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES